| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.07 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.07 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.07 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.093 | 0.08 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |